EUVIMEDEUVIMED entdecken
Crossref

Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers

Rebeca Lozano, Elena Castro, Fernando Lopez-Campos, Heather Thorne, Miguel Ramirez-Backhaus, Isabel M Aragon, Ylenia Cendón-Florez, Ana Gutierrez-Pecharroman, Daniela C Salles, Nuria Romero-Laorden, David Lorente, Pilar González-Peramato und 20 weitere

European Journal of Cancer · 2023-05 · 185 · 105-118

DOI: 10.1016/j.ejca.2023.02.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2023-05. Verfasst von Rebeca Lozano und 31 weiteren Autor:innen. Beteiligte Einrichtung: Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Department of Medical Oncolo…. Hauptthemen laut MEDLINE: DNA Copy Number Variations, Prostatic Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Instituto de Salud Carlos III, Sociedad Española de Oncología Médica, CRIS Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA Copy Number VariationsProstatic NeoplasmsMaleHumansBRCA2 ProteinHeterozygoteMutationGerm CellsGerm-Line Mutation

Stichwörter der Autor:innen

BRCA2Disease progressionGermlineProstate cancerSurvival outcomes

Substanzen

BRCA2 ProteinBRCA2 protein, human

Autor:innen und Institutionen

  • Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Department of Medical Oncology, Hospital Universitario de Salamanca, Salamanca, Spain.
  • Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Translational Cancer Genetics Group, Hospital Universitario 12 de Octubre, Madrid, Spain. Electron…
  • Department of Radiation Oncology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • kConFab, The Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Urology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain.
  • Genitourinary Cancer Translational Research Unit, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Sociedad Española de Oncología Médica
  • CRIS Cancer Foundation

Zitieren

APA

Lozano, R., Castro, E., Lopez-Campos, F., Thorne, H., Ramirez-Backhaus, M., Aragon, I. M., Cendón-Florez, Y., Gutierrez-Pecharroman, A., Salles, D. C., Romero-Laorden, N., Lorente, D., González-Peramato, P., Calatrava, A., Alonso, C., Anido, U., Arévalo-Lobera, S., Balmaña, J., Chirivella, I., Juan-Fita, M. J., …, & Olmos, D. (2023). Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. European Journal of Cancer, 185, 105-118. https://doi.org/10.1016/j.ejca.2023.02.022

Vancouver

Lozano R, Castro E, Lopez-Campos F, Thorne H, Ramirez-Backhaus M, Aragon IM, et al. Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers. European Journal of Cancer. 2023;185:105-118. doi:10.1016/j.ejca.2023.02.022

BibTeX
@article{Lozano2023,
  author = {Lozano, Rebeca and Castro, Elena and Lopez-Campos, Fernando and Thorne, Heather and Ramirez-Backhaus, Miguel and Aragon, Isabel M and Cendón-Florez, Ylenia and Gutierrez-Pecharroman, Ana and Salles, Daniela C and Romero-Laorden, Nuria and Lorente, David and González-Peramato, Pilar and Calatrava, Ana and Alonso, Concepción and Anido, Urbano and Arévalo-Lobera, Sara and Balmaña, Judith and Chirivella, Isabel and Juan-Fita, María José and Llort, Gemma and Y Cajal, Teresa Ramón and Almagro, Elena and Alameda, Daniel and López-Casas, Pedro P and Herrera, Bernardo and Mateo, Joaquin and Pritchard, Colin C and Antonarakis, Emmanuel S and Lotan, Tamara L and Rubio-Briones, José and Sandhu, Shahneen and Olmos, David},
  title = {Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers},
  journal = {European Journal of Cancer},
  year = {2023},
  volume = {185},
  pages = {105--118},
  doi = {10.1016/j.ejca.2023.02.022}
}
Kostenlos starten →